Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Stinker

<< Previous

Bullboard Posts

Next >>

Comment by Peladawnon Jul 23, 2024 9:37am

59 Views

Post# 36144040

RE:RE:RE:RE:Stinker

How exactly does "my side do the same thing"?.....that's where I'm having a hard time understanding wtf you're talking about.....it's super easy to say something that isn't true, but not so easy to defend it....so, I ask you again.....show us proof that "my side does the same thing"......and PLEASE don't make your argument look even dumber than it is already by referencing something that Joy Reid said or the lady hacks of "The View".

<< Previous

Bullboard Posts

Next >>

The long-term forecast for lithium stocks in 2024